Literature DB >> 16830130

MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.

K P C Kuypers1, N Samyn, J G Ramaekers.   

Abstract

RATIONALE: The party drug ecstasy is frequently used in combination with other drugs like marihuana and alcohol. In addition, a substantial proportion of the MDMA users has claimed to drive a car when under the influence of MDMA and/or other drugs.
OBJECTIVE: To assess the effects of MDMA and alcohol, combined and alone, on actual driving performance and laboratory tasks related to driving.
METHODS: Eighteen healthy subjects participated in a double-blind, placebo-controlled, six-way cross-over study. Treatments consisted of MDMA 0, 75, and 100 mg with and without alcohol, aiming at 0.06 mg/ml BAC. Laboratory tests (critical tracking task, object movement estimation task) were conducted between 1.5 and 2 h postdrug (0.5 and 1 h postalcohol). Actual driving tests (road tracking test, car-following test) were conducted between 3 and 5 h postdrug (2 and 4 h postalcohol). Subjects completed the addiction research center inventory (ARCI) and rated their driving quality and mental effort during driving.
RESULTS: Alcohol alone impaired critical tracking performance, as well as a number of actual driving performance parameters [i.e., standard deviation of lateral position (SDLP), brake reaction time, and coherence]. MDMA alone reduced SDLP and standard deviation of speed. MDMA significantly moderated alcohol induced impairment of road tracking performance but did not affect alcohol impairments of car-following and laboratory task performance. Subjective data seemed to support objective data.
CONCLUSION: MDMA moderated the impairing effects of a low dose of alcohol on road tracking performance but it could not overcome alcohol-induced impairment on other aspects of driving behavior or driving related performance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830130     DOI: 10.1007/s00213-006-0434-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

Authors:  Cándido Hernández-López; Magí Farré; Pere N Roset; Esther Menoyo; Nieves Pizarro; Jordi Ortuño; Marta Torrens; Jordi Camí; Rafael de La Torre
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

2.  Marijuana, alcohol and actual driving performance.

Authors:  J. G. Ramaekers; H. W. J. Robbe; J. F. O'Hanlon
Journal:  Hum Psychopharmacol       Date:  2000-10       Impact factor: 1.672

3.  3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment.

Authors:  B K Logan; F J Couper
Journal:  J Forensic Sci       Date:  2001-11       Impact factor: 1.832

4.  Patterns of simultaneous polysubstance use in Canadian rave attendees.

Authors:  Sean P Barrett; Samantha R Gross; Isabelle Garand; Robert O Pihl
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

5.  A "critical" tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616.

Authors:  H R Jex; J D McDonnell; A V Phatak
Journal:  NASA Contract Rep NASA CR       Date:  1966-11

6.  Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.

Authors:  M Mas; M Farré; R de la Torre; P N Roset; J Ortuño; J Segura; J Camí
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

7.  Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans.

Authors:  H de Wit; J Crean; J B Richards
Journal:  Behav Neurosci       Date:  2000-08       Impact factor: 1.912

8.  Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

Authors:  R de la Torre; M Farré; J Ortuño; M Mas; R Brenneisen; P N Roset; J Segura; J Camí
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

9.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Authors:  J A Henry; K J Jeffreys; S Dawling
Journal:  Lancet       Date:  1992-08-15       Impact factor: 79.321

10.  Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991 and 2000.

Authors:  M Carmen del Río; Josefina Gómez; Manuel Sancho; F Javier Alvarez
Journal:  Forensic Sci Int       Date:  2002-06-25       Impact factor: 2.395

View more
  29 in total

Review 1.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

2.  Risky car following in abstinent users of MDMA.

Authors:  Elizabeth Dastrup; Monica N Lees; Antoine Bechara; Jeffrey D Dawson; Matthew Rizzo
Journal:  Accid Anal Prev       Date:  2010-05

3.  A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone.

Authors:  Arthur A Simen; Cynthia Gargano; Jang-Ho Cha; Melissa Drexel; An Bautmans; Ingeborg Heirman; Tine Laethem; Thomas Hochadel; Lien Gheyle; Kim Bleys; Chan Beals; Aubrey Stoch; Gary G Kay; Arie Struyk
Journal:  Ther Adv Drug Saf       Date:  2015-06

4.  Response to the comments by Cassel et al.

Authors:  G J H Dumont; R J Verkes; J K Buitelaar; J M A van Gerven
Journal:  Psychopharmacology (Berl)       Date:  2008-09-02       Impact factor: 4.530

5.  Ethanol and MDMA: a comment on the paper by Dumont et al.

Authors:  Jean-Christophe Cassel; Sami Ben Hamida; Byron C Jones
Journal:  Psychopharmacology (Berl)       Date:  2008-08-28       Impact factor: 4.530

6.  Blockade of 5-HT2 receptor selectively prevents MDMA-induced verbal memory impairment.

Authors:  J H P van Wel; K P C Kuypers; E L Theunissen; W M Bosker; K Bakker; J G Ramaekers
Journal:  Neuropsychopharmacology       Date:  2011-05-11       Impact factor: 7.853

7.  The acute effects of MDMA and ethanol administration on electrophysiological correlates of performance monitoring in healthy volunteers.

Authors:  D B Spronk; G J H Dumont; R J Verkes; E R A De Bruijn
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

8.  Effects of alcohol on automated and controlled driving performances.

Authors:  Catherine Berthelon; Guy Gineyt
Journal:  Psychopharmacology (Berl)       Date:  2013-11-30       Impact factor: 4.530

9.  Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver.

Authors:  Kwan-Hoon Moon; Vijay V Upreti; Li-Rong Yu; Insong J Lee; Xiaoying Ye; Natalie D Eddington; Timothy D Veenstra; Byoung-Joon Song
Journal:  Proteomics       Date:  2008-09       Impact factor: 3.984

10.  Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss.

Authors:  Wendy M Bosker; Kim P C Kuypers; Silke Conen; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.